Filing Details

Accession Number:
0001140361-15-034381
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-03 16:56:17
Reporting Period:
2015-09-01
Filing Date:
2015-09-03
Accepted Time:
2015-09-03 16:56:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO Surgical & Medical Instruments & Apparatus (3841) 562568057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1174533 F Michael Demane C/O Nevro Corp.
4040 Campbell Avenue
Menlo Park CA 94025
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-01 26,667 $45.02 600,608 No 4 S Direct
Common Stock Disposition 2015-09-02 6,667 $45.30 44,254 No 4 S Indirect See foonote
Common Stock Disposition 2015-09-02 6,667 $45.30 117,866 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See foonote
No 4 S Indirect See footnote
Footnotes
  1. The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.08, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Includes 8,795 shares previously held by The Michael F. DeMane 2012 Retained Annuity Trust u/a/d July 26, 2012 which were distributed to the Reporting Person on November 28, 2014 and are now owned directly.
  4. Includes 1,076 shares previously held by The Michael F. DeMane 2013 Retained Annuity Trust which were distributed to the Reporting Person on April 13, 2015 and are now owned directly.
  5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.50, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  6. Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.
  7. Shares held by The Michael F. DeMane 2012 Retained Annuity Trust u/a/d July 26, 2012.